A novel method for multiplex protein biomarker analysis of human serum using quantitative MALDI mass spectrometryArticle Published on 2022-02-202023-07-07 Journal: Journal of pharmaceutical and biomedical analysis [Category] COVID19(2023년), [키워드] (18)O isotope exchange Alpha-2-macroglobulin fetuin-A MALDI MS Quantitative mass spectrometry serum amyloid A [DOI] 10.1016/j.jpba.2021.114575
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional StudyArticle Published on 2021-12-182022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Admission alteration Anti-inflammatory anti-oxidative antioxidant Cohort COVID-19 COVID-19 patient COVID-19 patients dead patient early stage Features HDL Hospitalized in-hospital mortality Infection IRCCS Italian no difference no significant difference paraoxonase 1 activity raised reached reduction in Retrospective study SAA SARS-CoV-2 positivity serum amyloid A significantly triglycerides unit [DOI] 10.3390/jcm10245955 PMC 바로가기 [Article Type] Article
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin장기간 COVID-19/PASC(Post-Acute Sequelae of COVID-19)의 지속적인 응고 단백질 병리는 항플라스민 수치 증가를 동반합니다Original Investigation Published on 2021-08-232022-09-10 Journal: Cardiovascular Diabetology [Category] MERS, SARS, 진단, 치료기술, [키워드] accompanied acute COVID-19 acute infection acute respiratory syndrome acute respiratory syndrome coronavirus amyloid A Antiplasmin Anxiety benefit blood clot Blood clots breath characterized circulating clinical pathologies clotting Coagulopathies Coagulopathy Control control sample coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 phenotype Depression diabetes digested fatigue Fibrin(ogen) fibrinogen fibrinolysis fibrinolytic system fluorescence microscopy healthy individuals Hypercoagulation increase in individual Infection Inflammatory inhibit Long Long COVID/PASC Microclots muscle weakness oxygen oxygen exchange PASC Pathologies pathology Patient pellet persistent plasma plasma sample plasma samples platelet hyperactivation Protein proteomics regime respiratory Result SAA serum amyloid A severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 supernatant Support survivor Symptom Symptoms syndrome therapy Type Type 2 diabetes mellitus Volume weakness [DOI] 10.1186/s12933-021-01359-7 PMC 바로가기 [Article Type] Original Investigation
Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosisCOVID-19 환자의 중증도 및 예후를 예측하는 유용한 바이오마커로서의 혈청 아밀로이드 A 단백질Comparative Study Published on 2021-06-012022-09-11 Journal: International immunopharmacology [Category] MERS, 바이오마커, [키워드] Admission amyloid A Analysis Biomarker Biomarkers Combination control group coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 disease COVID-19 patient Critical cut-off cut-off value Cytokines D-dimer Disease progression high risk Hospitalization hsCRP identification identify IL-6 IMPROVE inflammatory biomarkers investigated liver management marker Mild non-survivor Non-survivors Patient Patient management poor prognosis predict pro-inflammatory cytokines procalcitonin produced prognostic Protein Retrospective study ROC Curve SAA SARS-CoV-2 serum serum amyloid A severity severity and prognosis survivor two group two groups [DOI] 10.1016/j.intimp.2021.107512 PMC 바로가기 [Article Type] Comparative Study
Hypothesis: AA amyloidosis is a factor causing systemic complications after coronavirus disease가설: AA 아밀로이드증은 코로나바이러스 질병 후 전신 합병증을 유발하는 요인입니다Article Commentary Published on 2021-04-202022-09-10 Journal: Prion [Category] 바이오마커, [키워드] AA amyloidosis amyloid A amyloidosis Biomarker cause chronic inflammation clinical picture Complication consequence coronavirus coronavirus disease Course COVID-19 COVID-19 infection cytokine cytokine production Cytokines Factor form Hypothesis induce Inflammation mind occur organ organs overproduction Protein provoke SAA serum amyloid serum amyloid A severe COVID-19 shown thrombosis tissues variety [DOI] 10.1080/19336896.2021.1910468 PMC 바로가기 [Article Type] Article Commentary
Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker염증성 류마티스 질환의 혈청 아밀로이드 A: 저명한 바이오마커에 대한 포괄적인 검토Review Published on 2021-02-192022-09-11 Journal: Frontiers in Immunology [Category] MERS, 바이오마커, [키워드] Activation acute phase amyloid A amyloidosis arising Arthritis autoinflammatory disease biological therapy Biomarker Biomarkers C-reactive protein C-reactive protein (CRP cascade clinical Clinical practice Clinical use clinical utility collected coronavirus disease Coronavirus disease 2019 COVID-19 database Disease activity disease severity erythrocyte sedimentation erythrocyte sedimentation rate ESR evaluated immune system Immunotherapy Inflammasome Inflammation Inflammatory interleukin interleukin 17 isoform lead management markers of inflammation mechanism Pathogenesis Patient patients producing Protein proteomic recent finding recruitment review rheumatic disease Rheumatic diseases rheumatic inflammatory disease rheumatoid arthritis SAA secondary amyloidosis sedimentation rate serum amyloid serum amyloid A severe coronavirus disease shown T helper cells target therapeutic strategy utility [DOI] 10.3389/fimmu.2020.631299 PMC 바로가기 [Article Type] Review
Prognostic value of serum amyloid A in patients with COVID-19Article Published on 2020-10-012023-07-11 Journal: Infection [Category] SARS, [키워드] COVID-19 Prognosis serum amyloid A [DOI] 10.1007/s15010-020-01468-7 PMC 바로가기
Associations between serum amyloid A, interleukin‐6, and COVID‐19: A cross‐sectional studyResearch Article Published on 2020-08-282022-10-30 Journal: Journal of Clinical Laboratory Analysis [Category] COVID-19, MERS, SARS, [키워드] addition Analysis analyzed auxiliary can be used Characteristics Clinical signs clinical symptom collected coronavirus disease COVID‐19 Critical Diseases dry cough elevated enrolled fatigue Fever healthy helping IL‐6 independent risk factor independent variable Inflammation interleukin‐6 Laboratory laboratory result Logistic regression NLR parameter Patient patients receiver operating characteristic Result ROC SAA serum amyloid serum amyloid A severe acute respiratory syndrome coronavirus 2 Severe patient severity significantly significantly higher was used were assessed [DOI] 10.1002/jcla.23527 PMC 바로가기 [Article Type] Research Article
Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19)Original Paper Published on 2020-07-272022-11-01 Journal: Epidemiology and Infection [Category] COVID-19, [키워드] 2019 novel coronavirus Acute phase reaction protein approach Asymptomatic Blood C-reactive protein change changes in Clinical management community-acquired pneumonia complement control groups control subject COVID-19 COVID-19 group COVID-19 patient COVID-19 patients CRP detect Diagnosis disease expression level fasting identify immunological characteristics IMPROVE indicated Mild moderate Patient prealbumin Prognosis progression Protein provided recruited SAA serum serum amyloid serum amyloid A severe patients significant increase significantly statistical analysis Study design suggested symptomatic patient the mean Treatment venous with COVID-19 [DOI] 10.1017/S095026882000165X PMC 바로가기 [Article Type] Original Paper
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosisArticle Published on 2020-04-082023-06-18 Journal: The Journal of Infection [Category] Fulltext, SARS, [키워드] C-reactive protein Computed tomography imaging Coronavirus disease 2019 lymphocyte serum amyloid A severity [DOI] 10.1016/j.jinf.2020.03.035 PMC 바로가기 [Article Type] Article